"This newly issued US patent is a counterpart of our European patent EP1774032 granted last year, which reinforces our IP position and global leadership in the field of protein engineering and molecular directed evolution" said Jean-François Bloch, Deputy General Manager and Intellectual Property Manager at Proteus
The patented technology belongs to the EvoSight™ protein
engineering platform, which also includes the L-Shuffling™
technology for gene shuffling. The invention provides
unprecedented insights in protein plasticity and potential of
evolution, hence dramatically accelerating the identification
of improved proteins variants. Based on the processing of
experimental data using a proprietary algorithm, it enables a
rational approach to randomized directed evolution processes
such as random mutagenesis.
This technology has already been successfully implemented for
developing new enzymes for industrial manufacturing processes
in a variety of fields including green chemistry, flavors and
fragrances and processing of bio-sourced feedstock. "For more
than ten years now, our scientists constantly develop
innovative tools in order to strengthen our competitive edge
in protein molecular directed evolution and accelerate the
development, industrialization and time-to-market of our
clients' products and processes" emphasized Gilles Ravot,
Chief Executive Officer at Protéus.
Protéus ( www.proteus.fr ) is a biotechnology company specialized in the design, development and implementation of sustainable industrial processes using enzymes and microbial strains. To fulfill this mission, Protéus benefits from a portfolio of proprietary technologies including a collection of exclusive microbial biodiversity, technologies for enzymes engineering and microbial strains optimization, and a platform of enzyme production and formulation to turn them into industrial tools. A member of the chemical Group PCAS, Protéus also benefits from the industrial capabilities and expertise of the Group. The PCAS Group ( www.pcas.com) is a fine and specialty chemicals Group which shares an ambition for excellence with its customers, which primarily include market-leading international groups. PCAS designs and delivers the best industrial solutions for its customers' specific expectations. These various expectations all share a common demand for safety, quality, competitiveness, innovation and sustainability.
ContactProtéus S.A.
Dr. Gilles Ravot
Tel : +33 (0)466 706464
email : gravot@proteus.fr info@proteus.fr www.proteus.fr